James R. Sheller

6.7k total citations
96 papers, 5.3k citations indexed

About

James R. Sheller is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, James R. Sheller has authored 96 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Physiology, 37 papers in Pulmonary and Respiratory Medicine and 19 papers in Pharmacology. Recurrent topics in James R. Sheller's work include Asthma and respiratory diseases (50 papers), Inflammatory mediators and NSAID effects (18 papers) and Respiratory and Cough-Related Research (15 papers). James R. Sheller is often cited by papers focused on Asthma and respiratory diseases (50 papers), Inflammatory mediators and NSAID effects (18 papers) and Respiratory and Cough-Related Research (15 papers). James R. Sheller collaborates with scholars based in United States, United Kingdom and Netherlands. James R. Sheller's co-authors include Ryszard Dworski, Daphne B. Mitchell, John A. Oates, Garrett Fitzgerald, Michael J. Holtzman, L. Jackson Roberts, Homer A. Boushey, R. Stokes Peebles, Joyce E. Johnson and A. J. J. Wood and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James R. Sheller

96 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. Sheller United States 44 2.7k 2.1k 868 796 753 96 5.3k
Hannu Kankaanranta Finland 45 3.2k 1.2× 2.4k 1.1× 1.2k 1.4× 364 0.5× 1.5k 2.0× 239 6.7k
Mark A. Birrell United Kingdom 45 2.4k 0.9× 2.2k 1.1× 1.2k 1.4× 394 0.5× 1.8k 2.4× 124 6.1k
Esteban Morcillo Spain 39 1.6k 0.6× 1.7k 0.8× 767 0.9× 323 0.4× 1.7k 2.3× 192 4.9k
Andrzej Szczeklik Poland 48 3.8k 1.4× 2.2k 1.1× 576 0.7× 3.3k 4.1× 516 0.7× 207 8.1k
Kunio Shirato Japan 49 2.2k 0.8× 2.1k 1.0× 869 1.0× 204 0.3× 1.7k 2.2× 248 9.7k
You Sook Cho South Korea 30 1.2k 0.5× 1.0k 0.5× 613 0.7× 285 0.4× 592 0.8× 157 3.1k
Hiromichi Suzuki Japan 43 1.4k 0.5× 906 0.4× 314 0.4× 324 0.4× 1.4k 1.9× 408 8.5k
Addison A. Taylor United States 45 1.1k 0.4× 514 0.2× 620 0.7× 478 0.6× 1.3k 1.8× 187 6.9k
Magnus Bäck Sweden 49 1.3k 0.5× 1.2k 0.6× 2.0k 2.3× 570 0.7× 2.1k 2.8× 190 8.5k
L. Jackson Roberts United States 29 919 0.3× 416 0.2× 441 0.5× 502 0.6× 1.2k 1.5× 56 3.9k

Countries citing papers authored by James R. Sheller

Since Specialization
Citations

This map shows the geographic impact of James R. Sheller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Sheller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Sheller more than expected).

Fields of papers citing papers by James R. Sheller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Sheller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Sheller. The network helps show where James R. Sheller may publish in the future.

Co-authorship network of co-authors of James R. Sheller

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Sheller. A scholar is included among the top collaborators of James R. Sheller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Sheller. James R. Sheller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, Nicole, Lindsay J. Celada, Jose D. Herazo‐Maya, et al.. (2014). Blockade of the Programmed Death-1 Pathway Restores Sarcoidosis CD4+ T-Cell Proliferative Capacity. American Journal of Respiratory and Critical Care Medicine. 190(5). 560–571. 97 indexed citations
2.
Hashimoto, Koichi, Joan E. Durbin, Weisong Zhou, et al.. (2005). Respiratory syncytial virus infection in the absence of STAT1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. Journal of Allergy and Clinical Immunology. 116(3). 550–557. 99 indexed citations
3.
Peebles, R. Stokes, Koichi Hashimoto, James R. Sheller, et al.. (2005). Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent. The Journal of Immunology. 175(12). 8253–8259. 17 indexed citations
4.
Hashimoto, Koichi, James R. Sheller, Jason D. Morrow, et al.. (2005). Cyclooxygenase Inhibition Augments Allergic Inflammation through CD4-Dependent, STAT6-Independent Mechanisms. The Journal of Immunology. 174(1). 525–532. 30 indexed citations
5.
Aronica, Mark, Susan A. McCarthy, Shadi Swaidani, et al.. (2003). Recall Helper T Cell Response. American Journal of Respiratory and Critical Care Medicine. 169(5). 587–595. 19 indexed citations
6.
Peebles, R. Stokes, Koichi Hashimoto, Jason D. Morrow, et al.. (2002). Selective Cyclooxygenase-1 and -2 Inhibitors Each Increase Allergic Inflammation and Airway Hyperresponsiveness in Mice. American Journal of Respiratory and Critical Care Medicine. 165(8). 1154–1160. 96 indexed citations
7.
Dworski, Ryszard, L. Jackson Roberts, John Murray, et al.. (2001). Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2‐isoprostane, 15‐F2t‐IsoP (8‐iso‐PGF). Clinical & Experimental Allergy. 31(3). 387–390. 80 indexed citations
8.
Brightling, Christopher E., Richard J. Ward, Gerrit Woltmann, et al.. (2000). Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma. American Journal of Respiratory and Critical Care Medicine. 162(3). 878–882. 123 indexed citations
9.
Dworski, Ryszard, et al.. (2000). Prostaglandin E2 Decreases Allergen-stimulated Release of Prostaglandin D2 in Airways of Subjects with Asthma. American Journal of Respiratory and Critical Care Medicine. 162(2). 637–640. 79 indexed citations
10.
Peebles, R. Stokes, Ryszard Dworski, Robert D. Collins, et al.. (2000). Cyclooxygenase Inhibition Increases Interleukin 5 and Interleukin 13 Production and Airway Hyperresponsiveness in Allergic Mice. American Journal of Respiratory and Critical Care Medicine. 162(2). 676–681. 70 indexed citations
11.
Macfarlane, Alison, et al.. (2000). Sputum Cysteinyl Leukotrienes Increase 24 Hours after Allergen Inhalation in Atopic Asthmatics. American Journal of Respiratory and Critical Care Medicine. 161(5). 1553–1558. 75 indexed citations
12.
Dworski, Ryszard, et al.. (1999). Allergen-induced Synthesis of F2-Isoprostanes in Atopic Asthmatics: Evidence for Oxidant Stress. American Journal of Respiratory and Critical Care Medicine. 160(6). 1947–1951. 104 indexed citations
13.
Pavord, Ian, Richard J. Ward, Gerrit Woltmann, et al.. (1999). Induced Sputum Eicosanoid Concentrations in Asthma. American Journal of Respiratory and Critical Care Medicine. 160(6). 1905–1909. 172 indexed citations
14.
Szczeklik, Andrzej, Ryszard Dworski, Lucyna Mastalerz, et al.. (1998). Salmeterol Prevents Aspirin-induced Attacks of Asthma and Interferes with Eicosanoid Metabolism. American Journal of Respiratory and Critical Care Medicine. 158(4). 1168–1172. 30 indexed citations
15.
Dworski, Ryszard, Colin Funk, John A. Oates, & James R. Sheller. (1997). Prednisone Increases PGH-Synthase 2 in Atopic Humans In Vivo. American Journal of Respiratory and Critical Care Medicine. 155(1). 351–357. 13 indexed citations
16.
Szczeklik, Andrzej, Krzysztof Sładek, Ryszard Dworski, et al.. (1996). Bronchial Aspirin Challenge Causes Specific Eicosanoid Response in Aspirin-Sensitive Asthmatics. American Journal of Respiratory and Critical Care Medicine. 154(6). 1608–1614. 143 indexed citations
17.
Sładek, Krzysztof, Ryszard Dworski, Jerzy Soja, et al.. (1994). Eicosanoids in Bronchoalveolar Lavage Fluid of Aspirin-Intolerant Patients with Asthma After Aspirin Challenge. American Journal of Respiratory and Critical Care Medicine. 149(4). 940–946. 127 indexed citations
18.
Dworski, Ryszard, Garrett Fitzgerald, John A. Oates, & James R. Sheller. (1994). Effect of Oral Prednisone on Airway Inflammatory Mediators in Atopic Asthma. American Journal of Respiratory and Critical Care Medicine. 149(4). 953–959. 227 indexed citations
19.
Sheller, James R., et al.. (1989). Thromboxane Biosynthesis in Allergen-induced Bronchospasm: Evidence for Platelet Activation. American Review of Respiratory Disease. 140(4). 932–935. 38 indexed citations
20.
Forman, Mervyn B., B. Hadley Wilson, James R. Sheller, et al.. (1987). Right ventricular hypertrophy is an important determinant of right ventricular infarction complicating acute inferior left ventricular infarction. Journal of the American College of Cardiology. 10(6). 1180–1187. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026